222 related articles for article (PubMed ID: 11533043)
1. beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis.
Claing A; Chen W; Miller WE; Vitale N; Moss J; Premont RT; Lefkowitz RJ
J Biol Chem; 2001 Nov; 276(45):42509-13. PubMed ID: 11533043
[TBL] [Abstract][Full Text] [Related]
2. The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization.
Mukherjee S; Gurevich VV; Jones JC; Casanova JE; Frank SR; Maizels ET; Bader MF; Kahn RA; Palczewski K; Aktories K; Hunzicker-Dunn M
Proc Natl Acad Sci U S A; 2000 May; 97(11):5901-6. PubMed ID: 10811902
[TBL] [Abstract][Full Text] [Related]
3. β-Arrestin-mediated Angiotensin II Signaling Controls the Activation of ARF6 Protein and Endocytosis in Migration of Vascular Smooth Muscle Cells.
Charles R; Namkung Y; Cotton M; Laporte SA; Claing A
J Biol Chem; 2016 Feb; 291(8):3967-81. PubMed ID: 26703465
[TBL] [Abstract][Full Text] [Related]
4. Arf6 negatively controls the rapid recycling of the β2 adrenergic receptor.
Macia E; Partisani M; Paleotti O; Luton F; Franco M
J Cell Sci; 2012 Sep; 125(Pt 17):4026-35. PubMed ID: 22611259
[TBL] [Abstract][Full Text] [Related]
5. The calcium-sensing receptor changes cell shape via a beta-arrestin-1 ARNO ARF6 ELMO protein network.
Bouschet T; Martin S; Kanamarlapudi V; Mundell S; Henley JM
J Cell Sci; 2007 Aug; 120(Pt 15):2489-97. PubMed ID: 17623778
[TBL] [Abstract][Full Text] [Related]
6. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.
Goodman OB; Krupnick JG; Santini F; Gurevich VV; Penn RB; Gagnon AW; Keen JH; Benovic JL
Nature; 1996 Oct; 383(6599):447-50. PubMed ID: 8837779
[TBL] [Abstract][Full Text] [Related]
7. Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between beta-arrestins and AP-2.
Hamdan FF; Rochdi MD; Breton B; Fessart D; Michaud DE; Charest PG; Laporte SA; Bouvier M
J Biol Chem; 2007 Oct; 282(40):29089-100. PubMed ID: 17675294
[TBL] [Abstract][Full Text] [Related]
8. Centaurin-alpha 1, an ADP-ribosylation factor 6 GTPase activating protein, inhibits beta 2-adrenoceptor internalization.
Lawrence J; Mundell SJ; Yun H; Kelly E; Venkateswarlu K
Mol Pharmacol; 2005 Jun; 67(6):1822-8. PubMed ID: 15778454
[TBL] [Abstract][Full Text] [Related]
9. beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin.
Laporte SA; Miller WE; Kim KM; Caron MG
J Biol Chem; 2002 Mar; 277(11):9247-54. PubMed ID: 11777907
[TBL] [Abstract][Full Text] [Related]
10. ARF6 regulates angiotensin II type 1 receptor endocytosis by controlling the recruitment of AP-2 and clathrin.
Poupart ME; Fessart D; Cotton M; Laporte SA; Claing A
Cell Signal; 2007 Nov; 19(11):2370-8. PubMed ID: 17719203
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex.
Naga Prasad SV; Laporte SA; Chamberlain D; Caron MG; Barak L; Rockman HA
J Cell Biol; 2002 Aug; 158(3):563-75. PubMed ID: 12163475
[TBL] [Abstract][Full Text] [Related]
12. Methods to Investigate the β-Arrestin-Mediated Control of ARF6 Activation to Regulate Trafficking and Actin Cytoskeleton Remodeling.
Charles R; Bourmoum M; Campbell S; Claing A
Methods Mol Biol; 2019; 1957():159-168. PubMed ID: 30919353
[TBL] [Abstract][Full Text] [Related]
13. The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits.
Laporte SA; Oakley RH; Holt JA; Barak LS; Caron MG
J Biol Chem; 2000 Jul; 275(30):23120-6. PubMed ID: 10770944
[TBL] [Abstract][Full Text] [Related]
14. G protein-coupled receptor endocytosis in ADP-ribosylation factor 6-depleted cells.
Houndolo T; Boulay PL; Claing A
J Biol Chem; 2005 Feb; 280(7):5598-604. PubMed ID: 15590645
[TBL] [Abstract][Full Text] [Related]
15. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
16. Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization.
Zhang J; Ferguson SS; Barak LS; Ménard L; Caron MG
J Biol Chem; 1996 Aug; 271(31):18302-5. PubMed ID: 8702465
[TBL] [Abstract][Full Text] [Related]
17. Role of arrestins in endocytosis and signaling of alpha2-adrenergic receptor subtypes.
DeGraff JL; Gagnon AW; Benovic JL; Orsini MJ
J Biol Chem; 1999 Apr; 274(16):11253-9. PubMed ID: 10196213
[TBL] [Abstract][Full Text] [Related]
18. Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor.
Jones BW; Hinkle PM
J Biol Chem; 2005 Nov; 280(46):38346-54. PubMed ID: 16183993
[TBL] [Abstract][Full Text] [Related]
19. Heterologous inhibition of G protein-coupled receptor endocytosis mediated by receptor-specific trafficking of beta-arrestins.
Klein U; Müller C; Chu P; Birnbaumer M; von Zastrow M
J Biol Chem; 2001 May; 276(20):17442-7. PubMed ID: 11278476
[TBL] [Abstract][Full Text] [Related]
20. Characterization of dominant negative arrestins that inhibit beta2-adrenergic receptor internalization by distinct mechanisms.
Orsini MJ; Benovic JL
J Biol Chem; 1998 Dec; 273(51):34616-22. PubMed ID: 9852134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
